TY  - JOUR
AU  - Mao, Ziling
AU  - Baker, Jacqueline Roshelli
AU  - Takeuchi, Masayoshi
AU  - Hyogo, Hideyuki
AU  - Tjønneland, Anne
AU  - Eriksen, Anne Kirstine
AU  - Severi, Gianluca
AU  - Rothwell, Joseph
AU  - Laouali, Nasser
AU  - Katzke, Verena
AU  - Kaaks, Rudolf
AU  - Schulze, Matthias B
AU  - Palli, Domenico
AU  - Sieri, Sabina
AU  - de Magistris, Maria Santucci
AU  - Tumino, Rosario
AU  - Sacerdote, Carlotta
AU  - Derksen, Jeroen W G
AU  - Gram, Inger T
AU  - Skeie, Guri
AU  - Sandanger, Torkjel M
AU  - Quirós, Jose Ramón
AU  - Crous-Bou, Marta
AU  - Sánchez, Maria-Jose
AU  - Amiano, Pilar
AU  - Colorado-Yohar, Sandra M
AU  - Guevara, Marcela
AU  - Harlid, Sophia
AU  - Johansson, Ingegerd
AU  - Perez-Cornago, Aurora
AU  - Freisling, Heinz
AU  - Gunter, Marc
AU  - Weiderpass, Elisabete
AU  - Heath, Alicia K
AU  - Aglago, Elom
AU  - Jenab, Mazda
AU  - Fedirko, Veronika
TI  - Pre-diagnostic Serum Glyceraldehyde-Derived Advanced Glycation End Products and Mortality Among Colorectal Cancer Patients.
JO  - International journal of cancer
VL  - 152
IS  - 11
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2023-00237
SP  - 2257-2268
PY  - 2023
N1  - 2023 Jun 1;152(11):2257-2268
AB  - Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties. However, the association of glycer-AGEs with mortality after colorectal cancer diagnosis has not been previously investigated. Circulating glycer-AGEs were measured by competitive ELISA. Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) and corresponding 95
KW  - Glyceraldehyde-derived advanced glycation end products (Other)
KW  - advanced glycation end products (Other)
KW  - colorectal cancer (Other)
KW  - mortality (Other)
KW  - prospective study (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:36715363
DO  - DOI:10.1002/ijc.34449
UR  - https://inrepo02.dkfz.de/record/212552
ER  -